Skip to content

Psilocybin: all studies

Page 179 of 440: studies 1,781 to 1,790 of 4,392, newest first. Back to the psilocybin overview

Research

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

Journal of Psychopharmacology September 20, 2010 Erich Studerus, Michael Kometer, Felix Hasler et al. 529 citations

Psilocybin and related hallucinogenic compounds are increasingly used in human research. However, due to limited information about potential subjective side effects, the controlled medical use of these compounds has remained controversial. We therefore analysed acute, short- and long-term subjective effects of psilocybin in healthy humans by pooling raw data from eight double-blind...

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

Archives of General Psychiatry September 7, 2010 Gurpreet S Chopra, Marycie Hagerty, Charles S. Grob et al. 1,220 citations

CONTEXT: Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer. OBJECTIVE: To explore the safety and efficacy...

DOI: 10.1001/archgenpsychiatry.2010.116 (opens in new tab) Psilocybin Mood Clinical psychology Beck depression inventory +2

Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin.

International Journal of Drug Policy May 1, 2010 Colin Wark, John F Galliher 12 citations

This research focuses on the events leading to the 1968 U.S. federal prohibition of psilocybin. It is a study of duelling moral entrepreneurs-Timothy Leary and Richard Alpert vs. the Harvard University Administration. The goal is to show how the primary active compound in an ostensibly harmless fungus (the psilocybin mushroom) became controversial in less than a decade. We used books,...

DOI: 10.1016/j.drugpo.2009.08.004 (opens in new tab) Full text (opens in new tab) Psilocybin history Psilocybin criminalization Psilocybin prohibition Psychedelic history +15

The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability

Journal of Psychopharmacology April 15, 2010 Ben Sessa, Amanda Feilding, Robin Carhart-Harris et al. 53 citations

This study sought to assess the tolerability of intravenously administered psilocybin in healthy, hallucinogen-experienced volunteers in a mock-magnetic resonance imaging environment as a preliminary stage to a controlled investigation using functional magnetic resonance imaging to explore the effects of psilocybin on cerebral blood flow and activity. The present pilot study demonstrated that...

DOI: 10.1177/0269881110367445 (opens in new tab) Psilocybin Hallucinogen Tolerability Magnetic resonance imaging +2

Psilocybin slows binocular rivalry switching through serotonin modulation

Journal of Vision March 19, 2010 Olivia Carter, John D. Pettigrew, Felix Hasler et al. 3 citations

Binocular rivalry refers to the fluctuations in visual awareness/suppression that occur when different images are simultaneously presented to each eye. To explore the role of serotonin (5-HT) in binocular rivalry, this study investigated the affects of the hallucinogenic 5-HT1A&2A receptor agonist psilocybin (the active compound in “magic mushrooms”), alone and after pretreatment with the...

Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors

Journal of Vision March 17, 2010 Olivia Carter, David C. Burr, John D. Pettigrew et al. 6 citations

Increasing evidence suggests a link between attention, working memory, serotonin (5-HT) and prefrontal cortex activity. In an attempt to tease out the relationship between these elements, this study tested the effects of the hallucinogenic 5-HT1A/2A receptor agonist psilocybin alone and after pretreatment with the 5-HT2A antagonist ketanserin on multiple object tracking and spatial working...

ChemInform Abstract: Palladium‐Catalyzed Synthesis of Tryptamines and Tryptamine Homologues: Synthesis of Psilocin.

ChemInform March 2, 2010 Chunmei Hu, Hua Qin, Yuxin Cui et al.

AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.

Drug Metabolism and Disposition March 2010 Nenad Manevski, Mika Kurkela, Camilla Höglund et al.

We have examined the glucuronidation of psilocin, a hallucinogenic indole alkaloid, by the 19 recombinant human UDP-glucuronosyltransferases (UGTs) of subfamilies 1A, 2A, and 2B. The glucuronidation of 4-hydroxyindole, a related indole that lacks the N,N-dimethylaminoethyl side chain, was studied as well. UGT1A10 exhibited the highest psilocin glucuronidation activity, whereas the activities of...

Detection of Psilocybin Mushroom Analogs in Chocolate

The Chemical Educator December 1, 2009 Brandon Huskins, Christopher R. Dockery

In this experiment, tryptamine is used as a psilocin analog and is dispersed onto a Fisher brand cellulose laboratory sponge to simulate dehydrated mushrooms. The resulting “mushroom” material is ground, molded into chocolate, and presented to student groups for real-world and applied analyses. Students isolate the tryptamine from the chocolate using their knowledge of drug chemistry,...